Anika Therapeutics's top three insider shareholders as of June 06, 2026 are Cheryl R Blanchard (President, Ceo, Director, 258.79K shares), David Colleran (Evp, General Counsel, Corp Sec, 67.57K shares), Glenn R. Larsen (Director, 50.26K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John B Iii Henneman | - | 49,871 | 0 | 24 Jun, 2025 |
| William R Jellison | - | 20,403 | 0 | 24 Jun, 2025 |
| Susan L N Vogt | - | 50,213 | 0 | 24 Jun, 2025 |
| Cheryl R Blanchard | President, Ceo, Director | 258,788 | 0 | 17 Mar, 2026 |
| Ian Mcleod | Svp, Cao Treasurer | 24,107 | 0 | 17 Mar, 2026 |
| Joseph H Capper | - | 20,403 | 0 | 24 Jun, 2025 |
| Michael L Levitz | Evp, Cfo, Treasurer | 46,955 | 0 | 12 Mar, 2024 |
| Jeffery S Thompson | - | 31,575 | 0 | 16 Jun, 2023 |
| Glenn R. Larsen | - | 50,258 | 0 | 24 Jun, 2025 |
| David Colleran | Evp, General Counsel, Corp Sec | 67,570 | 0 | 17 Mar, 2026 |
| Thomas Finnerty | Evp, Human Resources | 24,598 | 0 | 11 Mar, 2022 |
| James Loerop | Evp Business Development | 5,592 | 0 | 12 Jul, 2021 |
| Stephen Richard | - | 47,871 | 0 | 24 Jun, 2025 |
| Gary P Fischetti | - | 41,613 | 0 | 24 Jun, 2025 |
| Anne Nunes | Svp, Chief Operations Officer | 20,654 | 0 | 18 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 13,097 | $0.00 | 13,097 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 13,097 | $0.00 | 13,097 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 11,194 | $0.00 | 11,194 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 11,194 | $0.00 | 11,194 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Premium Priced Stock Appreciation Rights | A | 17,663 | $0.00 | 17,663 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Premium Priced Stock Appreciation Rights | A | 17,663 | $0.00 | 17,663 | D | A |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 3,774 | - | 22,518 | D | M |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 3,774 | - | 22,518 | D | M |
| 14 Mar, 2026 | David Colleran | Common Stock | A | 9,388 | - | 62,488 | D | M |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | A | 24,519 | - | 235,969 | D | M |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 1,161 | $0.00 | 23,679 | D | A |
| 14 Mar, 2026 | David Colleran | Common Stock | A | 4,694 | $0.00 | 67,182 | D | A |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | A | 24,520 | $0.00 | 260,489 | D | A |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 1,161 | $0.00 | 23,679 | D | A |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | D | 14,728 | $14.20 | 245,761 | D | F |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | D | 1,449 | $14.20 | 22,230 | D | F |
| 14 Mar, 2026 | David Colleran | Common Stock | D | 4,168 | $14.20 | 63,014 | D | F |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | D | 1,449 | $14.20 | 22,230 | D | F |
| 15 Mar, 2026 | Ian Mcleod | Common Stock | A | 2,658 | - | 24,888 | D | M |
| 15 Mar, 2026 | Ian Mcleod | Common Stock | A | 2,658 | - | 24,888 | D | M |